Kaliumchlorid + Glucose Fresenius Kabi

Potassium chloride, the active ingredient in Kaliumchlorid + Glucose Fresenius Kabi, is an electrolyte solution presented as an injection solution for intravenous use. It corrects hypokalemia and supplies glucose to prevent hypoglycemia during IV therapy, helping maintain plasma osmolarity and cardiac stability.

GNH USA supplies Kaliumchlorid + Glucose Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kaliumchlorid + Glucose is used in clinical situations that require correction of electrolyte imbalances and glucose support during intravenous therapy. - Hypokalemia: restores plasma potassium levels to prevent cardiac arrhythmias. - Electrolyte replacement therapy: supplies essential potassium ions during fluid resuscitation. - Prevention of hypoglycemia during IV therapy: provides glucose as an energy source to maintain plasma osmolarity.

Adverse reactions may occur with any intravenous electrolyte solution and should be monitored.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Phlebitis: inflammation of the vein used for administration. - Transient hyperkalemia: temporary rise in serum potassium. - Hyperglycemia: elevated blood glucose levels.

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrest. - Anaphylactic reaction: severe allergic response. - Severe hyperglycemia with ketoacidosis. - Cardiac arrhythmias due to rapid potassium shifts. - Hemolysis from improper mixing.

Use of Kaliumchlorid + Glucose requires careful clinical assessment and monitoring. - Cardiac monitoring: observe ECG for arrhythmias when correcting severe hypokalemia. - Renal function: assess kidney function before administration as impaired excretion can raise potassium. - Blood glucose: monitor glucose levels in diabetic or critically ill patients. - Compatibility: verify compatibility with other IV solutions to avoid precipitation. - Infusion rate: administer at a controlled rate to avoid rapid shifts in electrolytes. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kaliumchlorid + Glucose can interact with several drug classes, requiring vigilance.

Major Interactions (Avoid): - ACE inhibitors: may increase serum potassium, risking hyperkalemia. - Potassium‑sparing diuretics: additive effect on potassium levels. - Insulin therapy: can cause rapid intracellular potassium shift. - Beta‑blockers: may potentiate hyperkalemia.

Moderate Interactions (Monitor Closely): - Loop diuretics: increased potassium loss may require dose adjustment. - Sodium bicarbonate: can raise serum potassium during alkalinisation. - Other glucose‑containing solutions: monitor for cumulative hyperglycaemia.